1. Home
  2. TECX vs MBI Comparison

TECX vs MBI Comparison

Compare TECX & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.57

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo MBIA Inc.

MBI

MBIA Inc.

HOLD

Current Price

$7.13

Market Cap

358.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
MBI
Founded
2019
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
358.5M
IPO Year
2018
1987

Fundamental Metrics

Financial Performance
Metric
TECX
MBI
Price
$20.57
$7.13
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$80.40
$8.50
AVG Volume (30 Days)
327.4K
398.6K
Earning Date
11-06-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$93,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
285.71
52 Week Low
$13.70
$3.86
52 Week High
$61.07
$8.26

Technical Indicators

Market Signals
Indicator
TECX
MBI
Relative Strength Index (RSI) 50.43 48.51
Support Level $18.99 $6.53
Resistance Level $21.86 $7.20
Average True Range (ATR) 1.28 0.34
MACD -0.02 0.01
Stochastic Oscillator 53.26 46.59

Price Performance

Historical Comparison
TECX
MBI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About MBI MBIA Inc.

MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.

Share on Social Networks: